

Chediak-Higashi Syndrome in children is a very rare condition that affects the immune system and vital body functions. It usually appears from birth or within the first few years of life, causing symptoms such as recurrent infections, skin and hair problems, and serious blood complications.In this Dalili Medical guide, we will explore the causes of Chediak-Higashi Syndrome, its symptoms, diagnostic methods, and the latest medical and surgical treatment options, providing parents with a comprehensive resource to better understand this rare condition and protect their child’s health.
Chediak-Higashi Syndrome (CHS) is a very rare genetic condition that affects the immune system, blood cells, skin, and hair. Children with CHS are more susceptible to recurrent and severe infections and may progress to a serious stage called the Accelerated Phase, which can be life-threatening.
CHS is caused by a genetic mutation in the LYST (CHS1) gene.
It is inherited in an autosomal recessive pattern, meaning the child must inherit the defective gene from both parents.
The mutation affects the function of white blood cells and platelets, weakening the immune system and causing bleeding or recurrent infections.
Immune problems: recurrent and severe infections.
Bleeding and bruising: due to low platelet count.
Hair and skin changes: early light-colored or gray hair, skin patches, or rashes.
Organ enlargement: enlarged liver or spleen.
Neurological or vision issues: may appear in some cases.
Blood tests: abnormal white blood cells and low platelets.
Immune function tests: to check the body’s ability to fight infections.
Genetic testing: to confirm the presence of the mutation.
Bone marrow biopsy: sometimes done to assess the impact of the disease.
Yes, CHS is an autosomal recessive disorder. A child must inherit the mutation from both parents to develop symptoms. Parents can be carriers without showing any signs.
Accelerated Phase: abnormal increase in blood cells, severe infections, and bleeding.
Persistent immune problems: making the child more prone to infections.
Organ damage: especially the liver and spleen.
Without medical intervention, these complications can be life-threatening.
Bone marrow transplant is the only definitive treatment, restoring normal immune function.
Medications, such as antibiotics or immunosuppressants, help control symptoms like infections or bleeding but do not cure the underlying genetic defect.
There is no way to prevent the genetic mutation itself.
Genetic counseling before pregnancy is highly recommended if there is a family history of CHS.
Without treatment, life expectancy is short due to infections, bleeding, or progression to the accelerated phase.
Early bone marrow transplant greatly improves survival chances.
Regular follow-up with pediatric immunologists and hematologists.
Prevent infections with vaccinations and daily hygiene measures.
Consider genetic counseling to prevent recurrence in future children.
Also known as Biegnez-César Syndrome, Leukocyte Abnormality with Albinism, or Natural Killer Cell Defect.
First described in 1943 by Dr. Biegnez César.
Extremely rare: only 200–500 cases reported worldwide.
Affects both boys and girls equally.
Can occur in any ethnicity, though not all cases are diagnosed or reported.
Without treatment, the prognosis is poor:
50–85% of children enter the life-threatening accelerated phase.
Most affected children die before age 10 without medical intervention.
Bone marrow transplant is the primary treatment to save the child’s life.
1️⃣ Early Stage (Birth to 5 Years)
Recurrent infections of the skin, respiratory tract, or urinary tract.
Very light hair and skin with occasional abnormal pigmentation.
Easy bruising and bleeding due to platelet dysfunction.
Infections become more frequent and may require strong antibiotics or hospitalization.
Enlargement of the liver and spleen is common.
Some children may show mild neurological issues, such as reduced motor skills or balance problems.
Usually appears between ages 2–5.
Symptoms include:
Persistent high fever.
Enlargement of the liver, spleen, and lymph nodes.
Severe anemia and low platelet count.
Damage to vital organs.
This phase is life-threatening, and bone marrow transplant is the primary treatment.
Recurrent infections continue throughout life.
Permanent neurological problems and delayed motor or cognitive development in some children.
Requires continuous medical care to maintain quality of life.
Early and accurate diagnosis is critical to determine proper treatment and prevent progression to the life-threatening accelerated phase. Diagnosis is based on:
Observation of light or pale hair and skin.
Presence of frequent bruising or bleeding due to low platelets.
Recurrent infections of the skin, respiratory tract, or urinary tract.
Examination of the liver and spleen, which are often enlarged.
Complete Blood Count (CBC): shows anemia, low platelets, or abnormal white blood cells.
Immune function tests: assess the body’s ability to fight infections.
Natural Killer (NK) cell activity test: evaluates immune efficiency.
Bone marrow biopsy: detects problems in blood cell production or abnormal cells.
Genetic analysis to detect mutations in the LYST gene, responsible for the disease.
Genetic testing provides definitive confirmation, especially if there is a family history.
Early diagnosis prevents progression to the accelerated phase, which is life-threatening.
The child usually needs care from a multidisciplinary team: pediatrician, immunologist, hematologist, and sometimes a genetic specialist.
CHS is a serious condition affecting the child’s immunity and overall health. The main risks include:
Frequent infections of the skin, respiratory tract (like pneumonia), and urinary tract.
Infections are often severe and may require strong antibiotics or hospitalization.
Low platelet counts make children prone to:
Easy bruising.
Bleeding from gums or nose.
In severe cases, internal bleeding may occur.
Caused by accumulation of abnormal blood cells.
Can lead to problems with blood storage and organ function.
The most dangerous stage of the disease.
Includes:
Severe infections.
Bone marrow failure.
Severe inflammation or organ failure.
This phase is life-threatening and requires urgent medical intervention.
Difficulty in nutrition and growth due to recurrent infections.
General weakness and low energy caused by anemia and other blood problems.
Early diagnosis and continuous monitoring reduce disease severity.
Children need care from a multidisciplinary medical team to maintain life quality and safety.
Chediak-Higashi Syndrome (CHS) is a rare genetic disorder affecting the immune system, skin, hair, and blood. Symptoms usually appear in early childhood. The main causes are:
The primary cause is a mutation in the LYST gene, which regulates immune cells and pigment cells.
This mutation leads to large, abnormal granules inside cells, weakening immunity and affecting hair and skin color.
CHS is inherited in an autosomal recessive pattern, meaning the child must inherit a defective gene from both parents.
Parents are usually carriers without showing symptoms.
The genetic mutation reduces white blood cell efficiency, making the child more prone to recurrent and severe infections, especially in the skin and respiratory tract.
Very light or gray hair from birth.
Pale skin or light patches due to pigment cell defects.
Platelet problems (easy bleeding and bruising).
Liver and spleen enlargement.
Increased risk of severe infections or rare blood disorders.
Light or gray hair from birth.
Pale skin or light patches.
Skin rashes or blisters due to recurrent infections.
Frequent infections in skin, ears, sinuses, and respiratory tract.
Severe infections may threaten life due to weak immunity.
Low platelets → easy bleeding and bruising.
Anemia may develop due to damaged blood cells.
Increased size due to abnormal blood cell accumulation.
Recurrent eye infections or vision issues.
Weak movement, balance problems, or delayed motor skills.
The most dangerous stage, with:
Persistent high fever.
Enlarged liver and spleen.
Severe anemia.
Abnormal white blood cell activity.
Requires urgent medical intervention, often bone marrow transplant or immune therapy.
Appears in early childhood.
Main symptoms: immune deficiency, light/gray hair, pale skin, easy bleeding, enlarged liver and spleen.
Children often enter the accelerated phase if untreated, requiring immune therapy or bone marrow transplant.
Symptoms are milder and appear later (late childhood or adolescence).
Infections are less severe.
Hair and skin may appear normal or nearly normal.
Partial gene mutation.
Symptoms are limited, and children may live without major problems.
Infections and organ enlargement are less severe; accelerated phase is rare.
Recurrent infections: skin, lungs, urinary tract.
Infections are often severe, requiring strong antibiotics.
Easy bruising and bleeding due to low platelet count or dysfunction.
Advanced cases may experience internal bleeding or severe anemia.
Can cause abdominal pain or bloating.
Affects blood cell production.
Most dangerous stage, often occurring early in life.
Symptoms: high fever, enlarged lymph nodes, severe anemia, affected organs.
Requires urgent medical treatment; bone marrow transplant is the primary solution.
Very light or gray hair from birth.
Pale skin compared to family.
Occasional skin patches or abnormal pigmentation.
In advanced cases, nerves may be affected.
Symptoms: difficulty in movement, balance, or coordination.
Skin, respiratory tract (e.g., pneumonia), and urinary tract.
Infections are serious, often requiring continuous antibiotic therapy.
Low platelets or platelet dysfunction leads to:
Easy bruising.
Nose or gum bleeding.
Internal bleeding in severe cases.
Due to accumulation of abnormal blood cells.
May cause blood storage or organ function problems.
Life-threatening stage in some children.
Characterized by:
Severe recurrent infections.
Bone marrow failure.
Multi-organ failure.
Requires urgent medical care.
Poor growth due to recurrent infections.
Weakness and low energy due to anemia and other blood issues.
Medications are supportive, managing complications but do not cure the genetic cause.
Treat or prevent recurrent infections.
Examples: amoxicillin or other antibiotics based on infection type.
Goal: reduce the risk of severe infections.
Drugs or injections to increase platelets or improve clotting.
Used in cases of severe bleeding or frequent bruising.
Goal: protect from internal and external bleeding.
Immune-suppressing drugs if the child enters this phase.
Examples: steroids (corticosteroids) or chemotherapy as decided by the doctor.
Goal: control abnormal cell activity and prepare for bone marrow transplant.
Nutritional supplements and vitamins to support growth and energy.
Medications for heart or respiratory support if advanced problems occur.
⚠️ Important Notes:
Medications are supportive only and do not address the underlying genetic cause.
Bone marrow transplant is the only treatment that can alter disease progression long-term.
Regular follow-up with a specialized medical team is essential.
With specialists: pediatricians, hematologists, immunologists.
Routine tests: CBC, liver and spleen function tests.
Goal: early detection of issues and prevention of complications.
Maintain hygiene and clean environment.
Stay up-to-date with vaccines.
Preventive antibiotics in some cases.
Avoid injuries or activities that may cause falls.
Monitor bleeding and consult doctor immediately.
Severe cases may require blood or platelet transfusion.
Balanced diet with adequate vitamins and minerals.
Monitor weight and height regularly.
Supplements may be needed to support energy and growth.
Bone marrow transplant is the only treatment that can change disease course.
Reduces risk of accelerated phase and improves immune function.
Requires careful evaluation by a specialized medical team.
Chronic disease requires continuous care, causing stress for parents and child.
Psychological support or support groups help families cope.
Extremely dangerous stage.
Symptoms: high fever, liver and spleen enlargement, organ problems.
Treatment: immune-suppressing drugs or bone marrow transplant, depending on condition.
Goal: replace diseased marrow with healthy cells from a compatible donor.
Benefits: improves immunity, reduces infection risk, stops accelerated phase.
Preparation: chemotherapy to reduce activity of old marrow before transplant.
Performed in rare cases with frequent bleeding or severe platelet deficiency.
Goal: reduce bleeding risk and protect child’s life.
If the child enters accelerated phase before transplant, surgical and intensive medical support may be needed to control bleeding and infections until transplant.
⚠️ Important Notes:
Most surgical interventions aim to support life and prepare the child for bone marrow transplant.
Medical team usually includes: pediatricians, immunologists, hematology surgeons, and critical care specialists.
Post-transplant, the child requires lifelong follow-up to monitor immunity and blood health.